Schell SL, Sennett ML, Feehan RP, Wallace TE, et al. Pilot study of topical ruxolitinib demonstrates efficacy and blunting of heterogeneous inflammatory processes in mild hidradenitis suppurativa. Br J Dermatol 2025;192:845-856.
PMID: 39708369